ACI
CNMD icon

AMP Capital Investors’s CONMED CNMD Stock Holding History

AMP Capital Investors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,586
Closed -$457K – 1201
2019
Q1 		$457K Buy
5,586
+95
+2% +$6.9K ﹤0.01% 984
2018
Q4 		$344K Hold
5,491
– – ﹤0.01% 1008
2018
Q3 		$437K Buy
+5,491
New +$425K ﹤0.01% 1022
2015
Q3 		– Sell
-3,669
Closed -$212K – 1202
2015
Q2 		$212K Buy
+3,669
New +$198K ﹤0.01% 1109
2015
Q1 		– Sell
-6,102
Closed -$274K – 1175
2014
Q4 		$274K Sell
6,102
-646
-10% -$27.1K ﹤0.01% 1067
2014
Q3 		$255K Buy
+6,748
New +$268K ﹤0.01% 1077

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AMP Capital Investors's CNMD Position: Q2 2019 in Review

AMP Capital Investors sold out of CONMED (CNMD) in Q2 2019, closing a stake of 5,586 shares — an estimated $457K sold.

AMP Capital Investors first reported a position in CNMD in Q3 2014 and held it in 6 quarters. The position peaked at $457K in Q1 2019. 230 funds tracked by Wall St. Rank hold CNMD as of Q2 2019.

  • AMP Capital Investors reported no remaining CONMED position as of Q2 2019 after selling out during the quarter.
  • AMP Capital Investors sold 5,586 CONMED shares in Q2 2019, an estimated $457K.
  • AMP Capital Investors first reported a position in CONMED in Q3 2014 and held it in 6 quarters.
  • AMP Capital Investors's CONMED position peaked at $457K in Q1 2019.
  • 230 funds tracked by Wall St. Rank held CONMED as of Q2 2019.

Based on AMP Capital Investors's 13F filing for Q2 2019, filed 14 Aug 2019.